Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation.
Van Goethem A, Deleu J, Yigit N, Everaert C, Moreno-Smith M, Vasudevan SA, Zeka F, Demuynck F, Barbieri E, Speleman F, Mestdagh P, Shohet J, Vandesompele J, Van Maerken T.
Van Goethem A, et al. Among authors: speleman f.
NAR Cancer. 2023 Jan 18;5(1):zcad002. doi: 10.1093/narcan/zcad002. eCollection 2023 Mar.
NAR Cancer. 2023.
PMID: 36683916
Free PMC article.